As of 2025-07-11, the Relative Valuation of Selecta Biosciences Inc (SELB) is (1.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Selecta Biosciences Inc based on Relative Valuation is -226.4%.
The range of the Relative Valuation is (2.03) - 0.85 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 18.9x | 13.4x |
| Forward P/E multiples | 25.3x - 33.7x | 32.9x |
| Fair Price | (2.03) - 0.85 | (1.11) |
| Upside | -330.2% - -3.2% | -226.4% |
| Date | P/E |